Real‐world long‐term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

Por Hideki Fujii, Hiroyuki Kimura, Chitomi Hasebe, Takehiro Akahane, Takashi Satou, Atsunori Kusakabe, Yuji Kojima, Masahiko Kondo, Hiroyuki Marusawa, Haruhiko Kobashi, Keiji Tsuji, Chikara Ogawa, Yasushi Uchida, Kouji Joko, Akeri Mitsuda, Masayuki Kurosaki, Namiki Izumi
Publicado em 2022-05-01

Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C

Por Jun Itakura, Masayuki Kurosaki, Satoru Kakizaki, Keisuke Amano, Nobuaki Nakayama, Jun Inoue, Tetsu Endo, Hiroyuki Marusawa, Chitomi Hasebe, Kouji Joko, Shuichi Wada, Takehiro Akahane, Youhei Koushima, Chikara Ogawa, Tatsuya Kanto, Masashi Mizokami, Namiki Izumi
Publicado em 2020-10-01